Distinctive roles of syntaxin binding protein 4 and its action target, TP63, in lung squamous cell carcinoma: a theranostic study for the precision medicine

BACKGROUND: Lung squamous cell carcinoma (LSCC) remains a challenging disease to treat, and further improvements in prognosis are dependent upon the identification of LSCC-specific therapeutic biomarkers and/or targets. We previously found that Syntaxin Binding Protein 4 (STXBP4) plays a crucial rol...

Descripción completa

Detalles Bibliográficos
Autores principales: Bilguun, Erkhem-Ochir, Kaira, Kyoichi, Kawabata-Iwakawa, Reika, Rokudai, Susumu, Shimizu, Kimihiro, Yokobori, Takehiko, Oyama, Tetsunari, Shirabe, Ken, Nishiyama, Masahiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7526255/
https://www.ncbi.nlm.nih.gov/pubmed/32993587
http://dx.doi.org/10.1186/s12885-020-07448-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7526255/
https://www.ncbi.nlm.nih.gov/pubmed/32993587
http://dx.doi.org/10.1186/s12885-020-07448-2

Ejemplares similares